MedTrace Logo

ENHANCE: A Prospective EvaluatioN of Permacol™ in tHe Repair of Complex AbdomiNal Wall CasEs

NCT01268514 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 115

Last updated 2024-05-10

Study results available
· View outcomes & findings →

Summary

The objective of this prospective study is to evaluate short-term, mid-term, and long-term clinical outcomes associated with the use of Permacol™ Biological Implant in the treatment of complex abdominal wall defects

Conditions

  • Hernia, Abdominal
  • Abdominal Injuries

Sponsors & Collaborators

  • Medtronic - MITG

    lead INDUSTRY

Principal Investigators

  • Pasquale Giordano, MD · Whipps Cross University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-02-28
Primary Completion
2016-11-30
Completion
2016-11-30

Countries

  • Belgium
  • Germany
  • Italy
  • Luxembourg
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01268514 on ClinicalTrials.gov